JENNIFER HOWARD: Open Payments
NPI 1740987189 · HUNTINGTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 37 payments from 9 companies in 2025. Trend: 2023 $27 · 2024 $257 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $201 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $196 |
| Teva Pharmaceuticals USA, Inc. | 3 | $58 |
| Vanda Pharmaceuticals Inc. | 2 | $41 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $28 |
| SI-BONE, INC. | 1 | $24 |
| Alkermes, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: REXULTI, CAPLYTA, AUSTEDO XR, FANAPT, ARISTADA, TRINTELLIX.
Industry payments across WV — which companies pay providers there.
